 |
|
Systemic vasculopathy associated with an RNF213 p.Arg4810Lys variant in moyamoya disease: A review
Duk-Kyung Kim, Shin Yi Jang, Sung-A Chang, Taek Kyu Park
Precis Future Med. 2022;6(3):155-160. Published online 2022 Aug 12 DOI: https://doi.org/10.23838/pfm.2022.00009
|
|
Citations to this article as recorded by
 Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213
Marzia Ognibene, Marcello Scala, Michele Iacomino, Irene Schiavetti, Francesca Madia, Monica Traverso, Sara Guerrisi, Marco Di Duca, Francesco Caroli, Simona Baldassari, Barbara Tappino, Ferruccio Romano, Paolo Uva, Diego Vozzi, Cristina Chelleri, Gianluc
Cancers.2023; 15(6): 1916. CrossRef RNF213 p.R4810K Variant Increases the Risk of Vasospastic Angina
Hiroyuki Ishiyama, Tomotaka Tanaka, Takeshi Yoshimoto, Atsushi Takahashi, Soshiro Ogata, Kunihiro Nishimura, Yoshihiro Asano, Akio Koizumi, Teruo Noguchi, Masafumi Ihara
JACC: Asia.2023;[Epub] CrossRef Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis
Rohin Singh, Megan M. J. Bauman, Andreas Seas, Daniel J. Harrison, Zach Pennington, Nolan J. Brown, Julian Gendreau, Redi Rahmani, Nathaniel Ellens, Joshua Catapano, Michael T. Lawton
Neurosurgical Review.2023;[Epub] CrossRef
|